|Ask||18.98 x 200|
|Day's Range||17.94 - 18.98|
|52 Week Range||12.51 - 19.35|
|PE Ratio (TTM)||-10.69|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Q1 2017 Albany Molecular Research Inc Earnings Call
The Albany, New York-based company said it had a loss of 25 cents per share. Earnings, adjusted for one-time gains and costs, came to 13 cents per share. The results beat Wall Street expectations. The ...
Drug manufacturer Albany Molecular Research Inc. is looking at a $1 billion sale, according to Bloomberg News. AMRI is working with Credit Suisse Group AG to explore a sale, Bloomberg reports, citing unidentified sources. Carlyle Group LP and Pamplona Capital Management, two private equity firms with records of investing in pharmaceutical and health care deals, have expressed interest.